BeStock  
Markets › Compare › BMRN vs BBIO

BMRN vs BBIO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BMRN · Biomarin Pharmaceutical$60.41 ▼ 1.64%
BBIO · BridgeBio Pharma$76.03 ▼ 2.75%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8797108119129Nov 24, '25May 26, '26Nov 20, '26
  • BMRN +8.8%
  • BBIO +7.1%

Head to head

MetricBMRNBBIO
Price$60.41$76.03
Change today▼ 1.64%▼ 2.75%
Market cap$11.70B$14.81B
Return, 3 months-7.2%-6.2%
Return, year to date+1.6%-0.6%
Return, 1 year+10.5%+11.6%
P/E (TTM)––
P/B1.9-5.7
P/E percentile vs own 5y0th1st
Dividend yield––
Revenue growth (YoY, latest qtr)+32.0%+192.6%
Net profit growth (YoY)-299.5%+67.3%
Gross margin76.0%94.3%
Operating margin4.9%-37.3%
Net margin-0.5%-62.6%
Return on equity-0.3%–
Analyst target vs. price+46.9%+44.7%
Analyst buy share74%94%
RSI (14)5955
30-day volatility31.8%37.8%
Max drawdown, 1 year-22.6%-29.8%
Trend readStrong uptrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BBIO is the largest of the group by market value.
  • BBIO has returned the most over the past year.
  • BBIO is growing revenue fastest.
  • BMRN keeps the most profit per dollar of sales.
  • BMRN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top